Literature DB >> 10806443

Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients.

C M Martin1, M S Lacomba, C I Molina, R R Chamond, J M Galera, E C Estevez.   

Abstract

PURPOSE: To study the ocular and systemic behaviour of the immune activation markers soluble ICAM-1 and soluble IL-2R in patients with active uveitis.
METHODS: We determined the levels of soluble ICAM-1 and soluble IL-2R in the aqueous humor and peripheral blood of 23 patients with active uveitis and 16 age and gender matched controls (who were to undergo cataract extraction) by means of ELISA enzyme immunoanalysis.
RESULTS: Patients with uveitis presented higher levels of soluble ICAM-1 and soluble IL-2R in the aqueous humor and peripheral blood. Comparison of the aqueous humor and peripheral blood revealed higher levels of soluble ICAM-1 in the aqueous humor, while we found no differences for soluble IL-2R. Analysis of the clinical characteristics of the uveitis we studied showed no differences in the levels of these markers in either blood or aqueous humor.
CONCLUSIONS: The finding of elevated levels of soluble IL-2R and soluble ICAM-1 in the aqueous humor and peripheral blood of patients with uveitis suggests the local and systemic participation of these markers in the pathogenesis of uveitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806443

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

Review 1.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

2.  Systemic inflammation and innate immune response in patients with previous anterior uveitis.

Authors:  M Huhtinen; H Repo; K Laasila; S-E Jansson; H Kautiainen; A Karma; M Leirisalo-Repo
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 3.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Authors:  R W J Lee; A D Dick
Journal:  Eye (Lond)       Date:  2011-09-30       Impact factor: 3.775

4.  Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Larry B Vogler
Journal:  Int J Clin Rheumtol       Date:  2013-02-01

Review 5.  Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis.

Authors:  Yi-Hsing Chen; Sue Lightman; Malihe Eskandarpour; Virginia L Calder
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

6.  Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

Authors:  Enken Gundlach; Michael Marcus Hoffmann; Antje Prasse; Sonja Heinzelmann; Thomas Ness
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.